United States - English - NLM (National Library of Medicine)

cephalon, llc - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av) - arsenic trioxide 2 mg in 1 ml - trisenox is indicated in combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (apl) whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. trisenox is indicated for induction of remission and consolidation in patients with apl who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the t(15;17) translocation or pml/rar-alpha gene expression. trisenox is contraindicated in patients with hypersensitivity to arsenic. risk summary based on the mechanism of action [see clinical pharmacology (12.1)] and findings in animal studies, trisenox can cause fetal harm when administered to a pregnant woman. arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m2  basis (see data) . a related trivalent arsenic, sodium arsen

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - arsenic trioxide, quantity: 10 mg - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - for the induction of remission and consolidation in patients with acute promyelocytic leukaemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.,for the induction of remission and consolidation in patients with previously untreated acute promyelocytic leukaemia (apl) in combination with all-trans retinoic acid (atra) and/or chemotherapy and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - arsenic trioxide, quantity: 12 mg - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - for the induction of remission and consolidation in patients with acute promyelocytic leukaemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.,for the induction of remission and consolidation in patients with previously untreated acute promyelocytic leukaemia (apl) in combination with all-trans retinoic acid (atra) and/or chemotherapy and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.

Canada - English - Health Canada

boiron laboratoires - arsenic trioxide - tablet - 3ch - arsenic trioxide 3ch - homeopathic products

United States - English - NLM (National Library of Medicine)

guna spa - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), lachesis muta venom (unii: vsw71ss07i) (lachesis muta venom - unii:vsw71ss07i), magnesium phosphate, tribasic, pentahydrate (unii: 453cof7817) (magnesium cation - unii:t6v3lhy838), matricaria recutita (unii: g0r4ubi2zz) (matricaria recutita - unii:g0r4ubi2zz), melatonin (unii: jl5dk93rcl) (melatonin - uni - arsenic trioxide 6 [hp_c] in 30 ml - arsenicum album 6c mood support beta-estradiol 6x vaginal dryness chamomilla 6c calming hydrastis canadensis 6c analgesic hypophysis 8x hormonal regulation lachesis mutus 4c anxiety magnesia phosphorica 6c metabolic support melatonin 4c hormonal balance nux vomica 6c mood support oophorinum 8x irregular menses progesterone 6x irregular menses sulfur 6c detoxification temporary relief of symptoms due to premenstrual syndrome such as: - moodiness - cramping - backache take 15 minutes before meals

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - arsenic trioxide, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - for the induction of remission and consolidation in patients with acute promyelocytic leukaemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression. for the induction of remission and consolidation in patients with previously untreated acute promyelocytic leukaemia (apl), in combination with all-trans retinoic acid (atra) and/or chemotherapy and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boiron - arsenicum album 4ch 1 % - pillules - 4ch - arsenicum album 4ch 1 %

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boiron - arsenicum album 5ch 1 % - pillules - 5ch - arsenicum album 5ch 1 %

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boiron - arsenicum album 7ch 1 % - pillules - 7ch - arsenicum album 7ch 1 %

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boiron - arsenicum album 9ch 1 % - pillules - 9ch - arsenicum album 9ch 1 %